342 related articles for article (PubMed ID: 8635847)
21. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
22. Status of drug resistance in tuberculosis after the introduction of rifampicin in India.
Paramasivan CN
J Indian Med Assoc; 2003 Mar; 101(3):154-6. PubMed ID: 14603961
[TBL] [Abstract][Full Text] [Related]
23. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
Sneag DB; Schaaf HS; Cotton MF; Zar HJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
[TBL] [Abstract][Full Text] [Related]
24. Drug-resistant tuberculosis in Budapest.
Fodor T; Vadász I; Lõrinczi I
Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
[TBL] [Abstract][Full Text] [Related]
25. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker TG; Lötter AP
Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
[No Abstract] [Full Text] [Related]
26. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
27. Latent tuberculosis infection in children: a call for revised treatment guidelines.
Finnell SM; Christenson JC; Downs SM
Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
[TBL] [Abstract][Full Text] [Related]
28. Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group.
Robert J; Trystram D; Truffot-Pernot C; Carbonnelle B; Grosset J
Int J Tuberc Lung Dis; 2000 Jul; 4(7):665-72. PubMed ID: 10907770
[TBL] [Abstract][Full Text] [Related]
29. Management of tuberculosis.
Meissner PE; Coulter JB
N Engl J Med; 2001 Nov; 345(20):1502. PubMed ID: 11794211
[No Abstract] [Full Text] [Related]
30. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
[TBL] [Abstract][Full Text] [Related]
31. An ounce of tuberculosis prevention.
Kornfeld H
Chest; 2008 Apr; 133(4):835-6. PubMed ID: 18398110
[No Abstract] [Full Text] [Related]
32. [Molecular medicine and treatment of tuberculosis].
Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
[No Abstract] [Full Text] [Related]
33. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
Gupta R; Raviglione MC; Espinal MA
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1078-9. PubMed ID: 11769764
[No Abstract] [Full Text] [Related]
34. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
35. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
[TBL] [Abstract][Full Text] [Related]
36. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
37. A sociodemographic study of multidrug resistant tuberculosis cases from DOTS clinics of Kolkata.
Gupta S; Bandyopadhyay D; Gupta S; Sadhukhan S; Banerjees S
J Indian Med Assoc; 2012 Oct; 110(10):723-5. PubMed ID: 23738405
[TBL] [Abstract][Full Text] [Related]
38. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
Lobato MN; Jereb JA; Castro KG
Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018
[No Abstract] [Full Text] [Related]
39. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
[TBL] [Abstract][Full Text] [Related]
40. Progress and challenges in childhood tuberculosis.
Marais BJ; Graham SM; Maeurer M; Zumla A
Lancet Infect Dis; 2013 Apr; 13(4):287-9. PubMed ID: 23531386
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
